COMPASS identifies T-cell subsets correlated with clinical outcomes

Nature Biotechnology

Volumn 33, Issue 6, 2015, Pages 610-616

  Lin, Lin ^a   Finak, Greg ^a   Ushey, Kevin ^a   Seshadri, Chetan ^b   Hawn, Thomas R ^b   Frahm, Nicole ^a   Scriba, Thomas J ^c   Mahomed, Hassan ^c   Hanekom, Willem ^c   Bart, Pierre Alexandre ^d   Pantaleo, Giuseppe ^d   Tomaras, Georgia D ^e   Rerks Ngarm, Supachai ^f   Kaewkungwal, Jaranit ^g   Nitayaphan, Sorachai ^h   Pitisuttithum, Punnee ^g   Michael, Nelson L ⁱ   Kim, Jerome H ⁱ   Robb, Merlin L ^j   O'Connell, Robert J ^h   Karasavvas, Nicos ^h   Gilbert, Peter ^a   De Rosa, Stephen C ^a,b   McElrath, M Juliana ^a,b   Gottardo, Raphael ^a   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f MINISTRY OF PUBLIC HEALTH   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

^h ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

ⁱ WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^j HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL CULTURE; CELL PROLIFERATION; CELLS; DISEASES; MOBILE SECURITY; OPEN SOURCE SOFTWARE; OPEN SYSTEMS; SET THEORY; SOFTWARE ENGINEERING; T-CELLS;

CELL POPULATION HETEROGENEITY; CLINICAL DATA SETS; COMPUTATIONAL FRAMEWORK; COMPUTATIONAL TOOLS; CYTOKINE PRODUCTION; HIGH-THROUGHPUT MEASUREMENTS; POSTERIOR PROBABILITY; SUMMARY STATISTIC;

CYTOLOGY;

CYTOKINE; ERDOSTEINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; VIRUS ENVELOPE PROTEIN;

ANALYTIC METHOD; ANTIGEN SPECIFICITY; ARTICLE; BAYES THEOREM; COMBINATORIAL POLYFUNCTIONALITY ANALYSIS OF ANTIGEN SPECIFIC T CELL SUBSETS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELLULAR IMMUNITY; CLINICAL TRIAL; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MALE; NORMAL HUMAN; PATHOGENICITY; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SINGLE CELL ANALYSIS; TREATMENT OUTCOME; VIROLOGY;

AIDS VACCINES; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE PRODUCTS, ENV; HEALTHY VOLUNTEERS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN A; MALE; SINGLE-CELL ANALYSIS; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME;

EID: 84930945915     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3187     Document Type: Article

References (30)

1. De Rosa, S.C. et al. Vaccination in humans generates broad T-cell cytokine responses. J. Immunol. 173, 5372-5380 (2004).
2. Attig, S. et al. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. Cancer Res. 69, 8412-8419 (2009).
3. Rodrigue-Gervais, I.G. et al. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J. Immunol. 184, 3134-3144 (2010).
4. Ciuffreda, D. et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur. J. Immunol. 38, 2665-2677 (2008).
5. Precopio, M.L. et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J. Exp. Med. 204, 1405-1416 (2007).
6. Darrah, P.A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13, 843-850 (2007).
7. Roederer, M., Nozzi, J.L. & Nason, M.X. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79, 167-174 (2011).
8. Aghaeepour, N. et al. Critical assessment of automated flow cytometry data analysis techniques. Nat. Methods 10, 228-238 (2013).
9. Lo, K., Brinkman, R.R. & Gottardo, R. Automated gating of flow cytometry data via robust model-based clustering. Cytometry A 73, 321-332 (2008).
10. Trigona, W.L. et al. Intracellular staining for HIV-specific IFN-gamma production: statistical analyses establish reproducibility and criteria for distinguishing positive responses. J. Interferon Cytokine Res. 23, 369-377 (2003).
11. Nason, M. Patterns of immune response to a vaccine or virus as measured by intracellular cytokine staining in flow cytometry: hypothesis generation and comparison of groups. J. Biopharm. Stat. 16, 483-498 (2006).
12. Horton, H. et al. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J. Immunol. Methods 323, 39-54 (2007).
13. Proschan, M.A. & Nason, M. Conditioning in 2 x 2 tables. Biometrics 65, 316-322 (2009).
14. Finak, G. et al. Mixture models for single-cell assays with applications to vaccine studies. Biostatistics 15, 87-101 (2014).
15. Larsen, M. et al. Evaluating cellular polyfunctionality with a novel polyfunctionality index. PLoS ONE 7, e42403 (2012).
16. Scott, J.G. & Berger, J.O. Bayes and empirical-Bayes multiplicity adjustment in the variable-selection problem. Ann. Stat. 38, 2587-2619 (2010).
17. Newton, M.A., Noueiry, A., Sarkar, D. & Ahlquist, P. Detecting differential gene expression with a semiparametric hierarchical mixture method. Biostatistics 5, 155-176 (2004).
18. Haynes, BF. et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275-1286 (2012).
19. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209-2220 (2009).
20. Mahomed, H. et al. Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int. J. Tuberc. Lung Dis. 15, 331-336 (2011).
21. Bart, P. et al. rAd5 prime/NYVAC-B boost regimen is superior to NYVAC-B prime/rAd5 boost regimen for both response rates and magnitude of CD4 and CD8 T-cell responses. Retrovirology 9 (suppl. 2), O72 (2012).
22. Reddy, T.B.K. et al. TB database: an integrated platform for tuberculosis research. Nucleic Acids Res. 37, D499-D508 (2009).
23. Bart, P.-A. et al. HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial. J. Clin. Invest. 124, 4843-4856 (2014).
24. McElrath, M.J. & Haynes, B.F. Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 33, 542-554 (2010).
25. Pai, M. et al. Gamma interferon release assays for detection of mycobacterium tuberculosis infection. Clin. Microbiol. Rev. 27, 3-20 (2014).
26. Ewer, K.J. et al. Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat. Commun. 4, 2836 (2013).
27. Overstreet, M.G., Cockburn, I.A., Chen, Y.-C. & Zavala, F. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an "unnatural" immune response. Immunol. Rev. 225, 272-283 (2008).
28. Derrick, S.C., Yabe, I.M., Yang, A. & Morris, S.L. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. Vaccine 29, 2902-2909 (2011).
29. Hawkridge, T. et al. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J. Infect. Dis. 198, 544-552 (2008).
30. De Rosa, S.C., Carter, D.K. & McElrath, M.J. OMIP-014: validated multifunctional characterization of antigen-specific human T cells by intracellular cytokine staining. Cytometry A 81, 1019-1021 (2012).